GSK_ Annual_Report_2021-22

Notes to the Consolidated Financial Statements for the year ended March 31, 2022 227 ( ` in lakhs ) As at March 31, 2022 As at March 31, 2021 For long term incentive plan (Refer Note 28 and 54) 4,14.14 2,85.61 For divestment / restructuring (Refer Note 28) 1,92.96 1,92.96 For others (Refer Note 28) 15,96.50 15,96.50 262,21.16 259,49.88 Note 22 : Current Borrowings ( ` in lakhs ) As at March 31, 2022 As at March 31, 2021 Current Maturity of Interest free deferred sales tax incentive - 2.40 - 2.40 Terms of repayment Interest free deferred sales tax incentive as at March 31, 2022 of ` Nil lakhs (March 31, 2021: ` 2.40 lakhs) availed under the 1993 Sales Tax Deferment Scheme. Note 23 : Current financial liabilities ( ` in lakhs ) As at March 31, 2022 As at March 31, 2021 Lease liabilities (Refer Note 48) 12,45.30 14,35.27 12,45.30 14,35.27 Note 24 : Trade payables ( ` in lakhs ) As at March 31, 2022 As at March 31, 2021 Total outstanding dues of micro enterprises and small enterprises (Refer Note 46) 7,92.72 5,26.94 Total outstanding dues of creditors other than micro enterprises and small enterprises 562,62.15 460,86.05 570,54.87 466,12.99 Trade Payables Ageing :- ( ` in lakhs ) Outstanding as at March 31, 2022 Unbilled Not due Less than 1 year 1-2 years 2-3 years More than 3 years Total (i) MSME - 7,02.61 81.12 0.06 3.42 5.51 7,92.72 (ii) Others 190,10.12 263,83.16 97,78.18 10,01.46 89.23 - 562,62.15 ( ` in lakhs ) Outstanding as at March 31, 2021 Unbilled Not due Less than 1 year 1-2 years 2-3 years More than 3 years Total (i) MSME - 3,87.78 1,25.38 6.53 0.20 7.05 5,26.94 (ii) Others 142,94.23 197,82.46 114,99.36 1,81.88 1,73.85 1,54.27 460,86.05